PI
Amsterdam institute for Immunology and Infectious Diseases
-
Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML
Tettero, J. M., Buisman, Y., Ngai, L. L., Bachas, C., Gjertsen, B. T., Kelder, A., van de Loosdrecht, A. A., Manz, M. G., Pabst, T., Scholten, W., Ossenkoppele, G. J., Cloos, J. & de Leeuw, D. C., 21 Dec 2023, In: HemaSphere. 7, 12, p. E981Research output: Contribution to journal › Article › Academic › peer-review
-
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine
Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) & Swiss Group for Clinical Cancer Research (SAKK), 1 Dec 2023, In: Blood Cancer Journal. 13, 1, 93.Research output: Contribution to journal › Article › Academic › peer-review
-
Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001
Janssen, L. L. G., Westers, T. M., Rovers, J., Valk, P. J. M., Cloos, J., de Gruijl, T. D. & van de Loosdrecht, A. A., 2 Nov 2023, In: HemaSphere. 7, 11, p. E968Research output: Contribution to journal › Letter › Academic › peer-review
- All publications